Blaeschke, F., Chen, Y., Apathy, R., Daniel, B., Chen, A.Y., Chen, P., Sandor, K., Zhang, W., Li, Z., Mowery, C.T., Yamamoto, T.N., Nyberg, W.A., To, A., Yu, R., Bueno, R., Kim, M., Schmidt, R., Goodman, D.B., Feuchtinger, T., Eyquem, J., Ye, C.J., Carnevale, J., Satpathy, A.T., Shifrut, E., Roth, T.L., and Marson, A. (2023). Modular Pooled Discovery of Synthetic Knockin Sequences to Program Durable Cell Therapies. Cell 186, 4216-4234 e4233.
Carnevale, J., Shifrut, E., Kale, N., Nyberg, W.A., Blaeschke, F., Chen, Y.Y., Li, Z., Bapat, S.P., Diolaiti, M.E., O'leary, P., Vedova, S., Belk, J., Daniel, B., Roth, T.L., Bachl, S., Anido, A.A., Prinzing, B., Ibanez-Vega, J., Lange, S., Haydar, D., Luetke-Eversloh, M., Born-Bony, M., Hegde, B., Kogan, S., Feuchtinger, T., Okada, H., Satpathy, A.T., Shannon, K., Gottschalk, S., Eyquem, J., Krenciute, G., Ashworth, A., and Marson, A. (2022). RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature 609, 174-182.
Schmidt, R., Steinhart, Z., Layeghi, M., Freimer, J.W., Bueno, R., Nguyen, V.Q., Blaeschke, F., Ye, C.J., and Marson, A. (2022). CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science 375, eabj4008
Blaeschke, F., Stenger, D., Apfelbeck, A., Cadilha, B.L., Benmebarek, M.R., Mahdawi, J., Ortner, E., Lepenies, M., Habjan, N., Rataj, F., Willier, S., Kaeuferle, T., Majzner, R.G., Busch, D.H., Kobold, S., and Feuchtinger, T. (2021). Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins. Blood Cancer J 11, 108.
